CleanGo Innovations Inc.

CGII.CN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CGII.CN stands at 10.1M. In comparison, KPT.TO has a market cap of 93.1M. Regarding current trading prices, CGII.CN is priced at CA$0.80, while KPT.TO trades at CA$9.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CGII.CN currently has a P/E ratio of -5.33, whereas KPT.TO's P/E ratio is 31.03. In terms of profitability, CGII.CN's ROE is +1.08%, compared to KPT.TO's ROE of +0.03%. Regarding short-term risk, CGII.CN is more volatile compared to KPT.TO. This indicates potentially higher risk in terms of short-term price fluctuations for CGII.CN.

CGII.CN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CGII.CN stands at 10.1M. In comparison, PPB.CN has a market cap of 15.4M. Regarding current trading prices, CGII.CN is priced at CA$0.80, while PPB.CN trades at CA$0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CGII.CN currently has a P/E ratio of -5.33, whereas PPB.CN's P/E ratio is -7.00. In terms of profitability, CGII.CN's ROE is +1.08%, compared to PPB.CN's ROE of -1.40%. Regarding short-term risk, CGII.CN is more volatile compared to PPB.CN. This indicates potentially higher risk in terms of short-term price fluctuations for CGII.CN.

CGII.CN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CGII.CN stands at 10.1M. In comparison, ZRO.CN has a market cap of 4.7M. Regarding current trading prices, CGII.CN is priced at CA$0.80, while ZRO.CN trades at CA$0.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CGII.CN currently has a P/E ratio of -5.33, whereas ZRO.CN's P/E ratio is -1.75. In terms of profitability, CGII.CN's ROE is +1.08%, compared to ZRO.CN's ROE of +0.30%. Regarding short-term risk, CGII.CN is more volatile compared to ZRO.CN. This indicates potentially higher risk in terms of short-term price fluctuations for CGII.CN.

CGII.CN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CGII.CN stands at 10.1M. In comparison, MAV.TO has a market cap of 1.7M. Regarding current trading prices, CGII.CN is priced at CA$0.80, while MAV.TO trades at CA$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CGII.CN currently has a P/E ratio of -5.33, whereas MAV.TO's P/E ratio is -0.01. In terms of profitability, CGII.CN's ROE is +1.08%, compared to MAV.TO's ROE of -2.47%. Regarding short-term risk, CGII.CN is more volatile compared to MAV.TO. This indicates potentially higher risk in terms of short-term price fluctuations for CGII.CN.

CGII.CN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CGII.CN stands at 10.1M. In comparison, WAY.CN has a market cap of 1.5M. Regarding current trading prices, CGII.CN is priced at CA$0.80, while WAY.CN trades at CA$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CGII.CN currently has a P/E ratio of -5.33, whereas WAY.CN's P/E ratio is N/A. In terms of profitability, CGII.CN's ROE is +1.08%, compared to WAY.CN's ROE of +0.00%. Regarding short-term risk, CGII.CN is more volatile compared to WAY.CN. This indicates potentially higher risk in terms of short-term price fluctuations for CGII.CN.

CGII.CN plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CGII.CN stands at 10.1M. In comparison, AHC.TO has a market cap of 0. Regarding current trading prices, CGII.CN is priced at CA$0.80, while AHC.TO trades at CA$4.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CGII.CN currently has a P/E ratio of -5.33, whereas AHC.TO's P/E ratio is 7.91. In terms of profitability, CGII.CN's ROE is +1.08%, compared to AHC.TO's ROE of +1.40%. Regarding short-term risk, CGII.CN is more volatile compared to AHC.TO. This indicates potentially higher risk in terms of short-term price fluctuations for CGII.CN.